by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
PE-22-28 (Spadin Analog PE-22-28) has emerged as one of the most studied peptides in modern biomedical research. With its 7 amino acids structure, this compound has attracted attention from researchers worldwide for its potential roles in neurogenesis and cognitive...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
In the ever-expanding landscape of peptide research, Dihexa occupies a notable position. This modified hexapeptide compound has been the subject of numerous studies investigating its role in Alzheimer research and memory enhancement. This article provides a detailed...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Peptide Research
Semax, also known as Semax Heptapeptide, is a 7 amino acids peptide that has garnered significant attention in the research community. Studies have explored its potential in ACTH analog, neuroprotection, and related fields, yielding a growing body of evidence that...
by Proxiva Peptides | Mar 29, 2026 | Nootropics, Research Guides
Research into Selank represents a fascinating intersection of molecular biology, pharmacology, and translational science. This 7 amino acids compound has shown promise in areas ranging from cognitive enhancement to immune support, making it a subject of considerable...
by Proxiva Peptides | Mar 7, 2026 | Nootropics, Peptide Research
Introduction: Nootropic vs Healing — Two Peptides With Overlapping Neuroprotective Properties Semax and BPC-157 occupy different categories in peptide pharmacology — Semax as a dedicated cognitive enhancer and neuroprotectant, BPC-157 as a systemic tissue repair...
by Proxiva Peptides | Mar 7, 2026 | Nootropics, Peptide Research
Introduction: Russia’s Two Flagship Nootropic Peptides Semax and Selank are two synthetic peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, both achieving regulatory approval in Russia and several CIS countries for...
